US · Healthcare

VitaSpring Biomedical Co. Ltd (VSBC)

Biotechnology

VitaSpring Biomedical Co. Ltd (VSBC) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for VSBC

P/E ratio

25.00

VitaSpring Biomedical Co. Ltd (VSBC) — FAQ

What is VSBC's P/E ratio?

The price-to-earnings (P/E) ratio for VitaSpring Biomedical Co. Ltd (VSBC) is 25.00 (data as of 2026-05-23).

Does VitaSpring Biomedical Co. Ltd pay a dividend?

Dividend yield is not available in the current snapshot for VitaSpring Biomedical Co. Ltd (VSBC). Check the MyAverix Finance app for the latest dividend data.

What sector is VitaSpring Biomedical Co. Ltd in?

VitaSpring Biomedical Co. Ltd (VSBC) is classified in the Healthcare sector (Biotechnology industry).

What exchange is VSBC listed on?

VSBC is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)